Development of a Formulation and In Vitro Evaluation of a Pulmonary Drug Delivery System for a Novel Janus Kinase (JAK) Inhibitor, CPL409116

Development of a Formulation and In Vitro Evaluation of a Pulmonary Drug Delivery System for a Novel Janus Kinase (JAK) Inhibitor, CPL409116

The pursuit of targeted therapies for cytokine-dependent diseases has led to the discovery of Janus kinase (JAK) inhibitors, a promising class of drugs. Among them, CPL409116, a selective dual JAK and rho-associated protein kinase inhibitor (ROCK), has demonstrated potential for treating conditions...

Full description

Saved in:
Bibliographic Details
Main Authors: Aleksandra Rzewińska (Author), Jakub Szlęk (Author), Damian Dąbrowski (Author), Ewelina Juszczyk (Author), Katarzyna Mróz (Author), Heikki Räikkönen (Author), Mia Siven (Author), Maciej Wieczorek (Author), Przemysław Dorożyński (Author)
Format: Book
Published: MDPI AG, 2024-08-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items